Clinical Trial Highlights: Modulators of Mitochondrial Function.
作者信息
Capriglia Francesco, Burgess Toby, Bandmann Oliver, Mortiboys Heather
机构信息
Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
出版信息
J Parkinsons Dis. 2023;13(6):851-864. doi: 10.3233/JPD-239003.
Abstract
摘要
相似文献
1
Clinical Trial Highlights: Modulators of Mitochondrial Function.
J Parkinsons Dis. 2023;13(6):851-864. doi: 10.3233/JPD-239003.
2
Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis.
Transl Psychiatry. 2022 Jan 10;12(1):4. doi: 10.1038/s41398-021-01727-7.
3
Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.
Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD006049. doi: 10.1002/14651858.CD006049.pub2.
4
Defining the short-term effects of pharmacological 5'-AMP activated kinase modulators on mitochondrial polarization, morphology and heterogeneity.
PeerJ. 2018 Aug 30;6:e5469. doi: 10.7717/peerj.5469. eCollection 2018.
5
Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.
Eur J Pharmacol. 2020 Jan 15;867:172847. doi: 10.1016/j.ejphar.2019.172847. Epub 2019 Dec 5.
6
Small-molecule cyclin-dependent kinase modulators.
Oncogene. 2003 Sep 29;22(42):6609-20. doi: 10.1038/sj.onc.1206954.
7
Targeting mitochondrial proteases for therapy of acute myeloid leukaemia.
Br J Pharmacol. 2022 Jul;179(13):3268-3282. doi: 10.1111/bph.15844. Epub 2022 Apr 15.
8
[Induction of cytosolic proteins controlling mitochondrial protein synthesis by thyroid hormone].
Nihon Naibunpi Gakkai Zasshi. 1985 Nov 20;61(11):1249-58. doi: 10.1507/endocrine1927.61.11_1249.
9
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.
Orphanet J Rare Dis. 2022 May 7;17(1):188. doi: 10.1186/s13023-022-02350-5.
10
Monoamine oxidase inhibitory modulators in rat heart cytosol: evidence for induction by thyroid hormone.
Endocrinology. 1982 Dec;111(6):1803-9. doi: 10.1210/endo-111-6-1803.
引用本文的文献
1
Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis.
J Med Chem. 2025 Jan 23;68(2):1970-1983. doi: 10.1021/acs.jmedchem.4c02741. Epub 2025 Jan 3.
本文引用的文献
1
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.
Mov Disord. 2023 Aug;38(8):1493-1502. doi: 10.1002/mds.29450. Epub 2023 May 29.
2
Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.
NPJ Parkinsons Dis. 2023 Apr 18;9(1):65. doi: 10.1038/s41531-023-00499-9.
3
Glycolysis-enhancing α-adrenergic antagonists modify cognitive symptoms related to Parkinson's disease.
NPJ Parkinsons Dis. 2023 Mar 2;9(1):32. doi: 10.1038/s41531-023-00477-1.
4
An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.
JMIR Res Protoc. 2023 Jan 30;12:e42032. doi: 10.2196/42032.
5
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study.
Sci Adv. 2023 Jan 13;9(2):eadd5163. doi: 10.1126/sciadv.add5163.
6
Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI-589 in Healthy Participants.
Clin Pharmacol Drug Dev. 2022 Oct;11(10):1136-1146. doi: 10.1002/cpdd.1146. Epub 2022 Aug 21.
7
Distinct Bile Acid Signature in Parkinson's Disease With Mild Cognitive Impairment.
Front Neurol. 2022 Jul 4;13:897867. doi: 10.3389/fneur.2022.897867. eCollection 2022.
8
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001.
9
Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice.
Cell Death Discov. 2022 Jan 17;8(1):28. doi: 10.1038/s41420-022-00826-8.
10
A pilot to assess target engagement of terazosin in Parkinson's disease.
Parkinsonism Relat Disord. 2022 Jan;94:79-83. doi: 10.1016/j.parkreldis.2021.11.022. Epub 2021 Nov 27.
Zotero 插件